Clinical reference laboratory market to reach $64.93 billion by 2030

The Business Research Company says the clinical reference laboratory market is on track to grow from $47 billion in 2025 to $50.24 billion in 2026, driven by rising diagnostic demand and broader use of advanced testing. The report projects further expansion to $64.93 billion by 2030, with North America leading now and Asia-Pacific set to grow fastest.

Why it matters: - Clinical reference laboratories support complex testing that guides diagnosis, treatment planning and patient monitoring. - Rising demand for diagnostic testing is widening the market for outsourced and specialized lab services. - Faster turnaround, more automation and broader genomic testing are reshaping how laboratories compete and scale.

What happened: - The Business Research Company published its Clinical Reference Laboratory Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report values the clinical reference laboratory market at $47 billion in 2025. - The market is forecast to reach $50.24 billion in 2026, a 6.9% CAGR. - The market is projected to climb to $64.93 billion by 2030, at a 6.6% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period.

The details: - Clinical reference laboratories conduct complex diagnostic analyses on blood, urine and tissue samples. - The labs provide molecular diagnostics, toxicology, immunology and pathology testing. - The report ties recent growth to chronic disease prevalence, hospital outsourcing, infectious disease testing, regulatory compliance and laboratory consolidation. - The forecast period is expected to benefit from genomic testing, AI-driven diagnostics, personalized medicine, digitized healthcare services and population-based screening. - The report highlights broader molecular diagnostics, greater automation, more complex testing, faster turnaround times and centralized diagnostic services as key trends. - The report says the market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - The report offers a free sample at the report sample. - The full report is available at the full market report.

Between the lines: - The market outlook suggests diagnostic demand is becoming less episodic and more embedded in routine care. - Pressure from delayed testing, especially in public systems, can accelerate outsourcing to reference labs. - The combination of AI, genomics and automation points to a shift toward higher-complexity, higher-throughput lab networks.

What's next: - The report expects growth to continue through 2030 as healthcare systems increase testing capacity and adopt more advanced diagnostics. - Asia-Pacific may gain share if demand for screening and specialized testing expands faster than in mature markets. - Reference laboratories will likely compete more on speed, specialization and digital workflow capability.